Cannabis Sativa, Inc. (OTCMKTS:CBDS) Files An 8-K Changes in Registrant’s Certifying AccountantITEM 4.01 Changes in Registrants’s Certifying Accountant.
Cannabis Sativa, Inc. (OTCMKTS:CBDS) Files An 8-K Changes in Registrant’s Certifying Accountant
Effective December 22, 2016, Cannabis Sativa, Inc. (the “Company”) dismissed Scrudato & Co., PA (“Scrudato”) from its position as the Company’s independent registered public accounting firm. The Company’s Board of Directors approved the dismissal. Scrudato’s dismissal was prompted by the revocation of its registration with the Public Company Accounting Oversight Board (“PCAOB”). The revocation of Scrudato’s registration was part of a sanction handed down by the PCAOB based upon findings that Scrudato violated PCAOB rules and standards in connection with the audits of five issuer clients, which five issuer clients did not include the Company.
The audit report of Scrudato on the Company’s financial statements for the year ended December 31, 2015, did not contain an adverse opinion or disclaimer of opinion, however it did contain a qualification describing a going concern uncertainty. Scrudato did not, during the applicable periods, advise the Company of any of the enumerated items described in Item 304(a)(1)(iv) of Regulation S-K.
During the period from the date of inception (November 17, 2015) through December 31, 2015, and the period to the date of this Current Report, there were no (i) disagreements between the Company and Scrudato on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to its satisfaction, would have caused Scrudato to make reference to the subject matter of such disagreements in connection with its report, or (ii) “reportable events,” as described in Item 304(a)(1)(v) of Regulation S-K, with the exception of material weaknesses related to our internal control over financial reporting.
The Company furnished Scrudato with a copy of this current report on Form 8-K prior to filing with the SEC and requested that Scrudato furnish it with a letter addressed to the SEC stating whether or not it agreed with the statements made by the Company in this report insofar as they relate to Scrudato’s audit services and engagement as the Company’s independent registered public accounting firm. Scrudato responded via email that he was in agreement with the disclosure in this current report on Form 8-K and would provide a letter stating his agreement with the disclosure, which letter would be attached to this filing as Exhibit 16.1. As of the date of this filing the Company has not received the letter but will amend this filing for the purpose of attaching the letter from Scrudato upon receipt.
PAGE
About Cannabis Sativa, Inc. (OTCMKTS:CBDS)
Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals, Inc. (Wild Earth). Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA (GDX), Face Garden, Body Garden and Lip Garden. Cannabis Sativa, Inc. (OTCMKTS:CBDS) Recent Trading Information
Cannabis Sativa, Inc. (OTCMKTS:CBDS) closed its last trading session up +0.01 at 5.32 with shares trading hands.
Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals, Inc. (Wild Earth). Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA (GDX), Face Garden, Body Garden and Lip Garden. Cannabis Sativa, Inc. (OTCMKTS:CBDS) Recent Trading Information
Cannabis Sativa, Inc. (OTCMKTS:CBDS) closed its last trading session up +0.01 at 5.32 with shares trading hands.
